Ed — at Pharmalot 3.0 — Catches Up To Our Fosamax® Femur Fracture MDL Post — Of Last Week

My buddy Ed is on this — using the New jersey Law Journal feed for his squib — in the Wall Street Journal.

As our readers know, we had this last weekend, on Saturday morning. It happened last Friday.

. . . .A federal judge in Trenton, N.J., dismissed the last remaining 570 cases [Editors’ NOTE: Femur Fracture Cases ONLY] in multidistrict litigation over Merck’s osteoporosis drug Fosamax, but the cases could be reinstated if plaintiffs win an appeal pending before a federal appeals court, The New Jersey Law Journal writes. . . .

So it goes. Onward. Ever, and ever. . . onward.

Advertisements

There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: